1
|
Chahat, Nainwal N, Murti Y, Yadav S, Rawat P, Dhiman S, Kumar B. Advancements in targeting tumor suppressor genes (p53 and BRCA 1/2) in breast cancer therapy. Mol Divers 2024:10.1007/s11030-024-10964-z. [PMID: 39152355 DOI: 10.1007/s11030-024-10964-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2024] [Accepted: 08/07/2024] [Indexed: 08/19/2024]
Abstract
Globally, among numerous cancer subtypes, breast cancer (BC) is one of the most prevalent forms of cancer affecting the female population. A female's family history significantly increases her risk of developing breast cancer. BC is caused by aberrant breast cells that proliferate and develop into tumors. It is estimated that 5-10% of breast carcinomas are inherited and involve genetic mutations that ensure the survival and prognosis of breast cancer cells. The most common genetic variations are responsible for hereditary breast cancer but are not limited to p53, BRCA1, and BRCA2. BRCA1 and BRCA2 are involved in genomic recombination, cell cycle monitoring, programmed cell death, and transcriptional regulation. When BRCA1 and 2 genetic variations are present in breast carcinoma, p53 irregularities become more prevalent. Both BRCA1/2 and p53 genes are involved in cell cycle monitoring. The present article discusses the current status of breast cancer research, spotlighting the tumor suppressor genes (BRCA1/2 and p53) along with structural activity relationship studies, FDA-approved drugs, and several therapy modalities for treating BC. Breast cancer drugs, accessible today in the market, have different side effects including anemia, pneumonitis, nausea, lethargy, and vomiting. Thus, the development of novel p53 and BRCA1/2 inhibitors with minimal possible side effects is crucial. We have covered compounds that have been examined subsequently (2020 onwards) in this overview which may be utilized as lead compounds. Further, we have covered mechanistic pathways to showcase the critical druggable targets and clinical and post-clinical drugs targeting them for their utility in BC.
Collapse
Affiliation(s)
- Chahat
- Department of Pharmaceutical Sciences, HNB Garhwal University, Chauras Campus, Srinagar, 246174, Uttarakhand, India
| | - Nidhi Nainwal
- Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Premanagar, Dehradun, 248007, Uttarakhand, India
| | - Yogesh Murti
- Institute of Pharmaceutical Research, GLA University, Mathura, 281406, India
| | - Savita Yadav
- IES Institute of Technology and Management, IES University, Bhopal, 462044, Madhya Pradesh, India
| | - Pramod Rawat
- Graphic Era (Deemed to Be University), Clement Town, Dehradun, 248002, India
- Graphic Era Hill University Clement Town, Dehradun, 248002, India
| | - Sonia Dhiman
- Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India
| | - Bhupinder Kumar
- Department of Pharmaceutical Sciences, HNB Garhwal University, Chauras Campus, Srinagar, 246174, Uttarakhand, India.
| |
Collapse
|
2
|
[4+2]-Cycloaddition to 5-Methylidene-Hydantoins and 5-Methylidene-2-Thiohydantoins in the Synthesis of Spiro-2-Chalcogenimidazolones. Int J Mol Sci 2023; 24:ijms24055037. [PMID: 36902468 PMCID: PMC10002963 DOI: 10.3390/ijms24055037] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2023] [Revised: 03/03/2023] [Accepted: 03/04/2023] [Indexed: 03/08/2023] Open
Abstract
Novel hydantion and thiohydantoin-based spiro-compounds were prepared via theDiels-Alder reactions between 5-methylidene-hydantoins or 5-methylidene-2-thiohydantoins and 1,3-dienes (cyclopentadiene, cyclohexadiene, 2,3-dimethylbutadiene, isoprene). It was shown that the cycloaddition reactions proceed regioselectively and stereoselectively with the formation of exo-isomers in the reactions with cyclic dienes andthe less sterically hindered products in the reactions with isoprene. Reactions of methylideneimidazolones with cyclopentadiene proceed viaco-heating the reactants; reactions with cyclohexadiene, 2,3-dimethylbutadiene, and isoprene require catalysis by Lewis acids. It was demonstrated that ZnI2 is an effective catalyst in the Diels-Alder reactions of methylidenethiohydantoins with non-activated dienes. The possibility of alkylation and acylation of the obtained spiro-hydantoinsat the N(1)nitrogen atoms with PhCH2Cl or Boc2O and the alkylation of the spiro-thiohydantoinsat the S atoms with MeI or PhCH2Cl in high yields have been demonstrated. The preparativetransformation of spiro-thiohydantoins into corresponding spiro-hydantoinsin mild conditions by treating with 35% aqueous H2O2 or nitrile oxide has been carried out. The obtained compounds show moderate cytotoxicity in the MTT test on MCF7, A549, HEK293T, and VA13 cell lines. Some of the tested compounds demonstrated some antibacterial effect against Escherichia coli (E. coli) BW25113 DTC-pDualrep2 but were almost inactive against E. coli BW25113 LPTD-pDualrep2.
Collapse
|
3
|
Chahat, Bhatia R, Kumar B. p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies. Eur J Med Chem 2023; 247:115020. [PMID: 36543034 DOI: 10.1016/j.ejmech.2022.115020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Revised: 12/05/2022] [Accepted: 12/11/2022] [Indexed: 12/23/2022]
Abstract
Cancer represents one of the world's biggest hazardous diseases. p53 is the uttermost researched tumour suppressor protein. It is commonly considered the "guardian of the genome," performing a critical function in genetic stability maintenance through controlling the cell cycle, programmed cell death, DNA repair, aging, and angiogenesis. The abnormalities in p53 lead to genetic instability and plays a significant role in carcinogenesis. The role of p53 in tumour suppression is emphasized in addition by the observation that primary silencing with this protein occurred in more than 50% of cancers. MDM2, p53, and the p53-MDM2 connections are well-known targets for the prevention and treatment of cancer. Moreover, in tumors with wild-type p53, their efficacy is decreased due to MDM2 enlargement or by the gradual decrease of MDM2 blocker ARF. As a result, improving p53 activity in cancerous cells provides a promising anticancer strategy. Various techniques are now being investigated, and addressing the p53-MDM2 interaction had also evolved as a potentially feasible strategy for contending with tumors. Both p53 and MDM2, interact via an autoregulation response signal: p53 activity induces MDM2 transcription, which in response interacts with p53's N-terminal transactivation domain, inhibiting its transcriptional activity. This article provides information on the current scenario of anti-tumor activities, with a particular emphasis on structure-activity relationship characteristics (SAR) against the p53-MDM2 to treat cancer. The primary purpose of this review is to cover recent advancements in the creation and testing of anticancer drugs that target the p53-MDM2 structure. This review contains different heterocyclic moieties which show significant results toward cancer. A mechanistic route is shown here, demonstrating both normal and malignant conditions via several stressed factors. Several compounds entered clinical trials as p53-MDM2 inhibitors for the treatment of cancer.
Collapse
Affiliation(s)
- Chahat
- Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Ghal Kalan, Ferozpur G.T. Road MOGA, 142001, Punjab, India
| | - Rohit Bhatia
- Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Ghal Kalan, Ferozpur G.T. Road MOGA, 142001, Punjab, India
| | - Bhupinder Kumar
- Department of Pharmaceutical Sciences, HNB Garhwal University, Chauras Campus, Srinagar, Garhwal, Uttarakhand, 246174, India.
| |
Collapse
|
4
|
Ivanenkov YA, Kukushkin ME, Beloglazkina AA, Shafikov RR, Barashkin AA, Ayginin AA, Serebryakova MS, Majouga AG, Skvortsov DA, Tafeenko VA, Beloglazkina EK. Synthesis and Biological Evaluation of Novel Dispiro-Indolinones with Anticancer Activity. Molecules 2023; 28:molecules28031325. [PMID: 36770991 PMCID: PMC9919490 DOI: 10.3390/molecules28031325] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Revised: 01/19/2023] [Accepted: 01/26/2023] [Indexed: 02/03/2023] Open
Abstract
Novel variously substituted thiohydantoin-based dispiro-indolinones were prepared using a regio- and diastereoselective synthetic route from 5-arylidene-2-thiohydantoins, isatines, and sarcosine. The obtained molecules were subsequently evaluated in vitro against the cancer cell lines LNCaP, PC3, HCTwt, and HCT(-/-). Several compounds demonstrated a relatively high cytotoxic activity vs. LNCaP cells (IC50 = 1.2-3.5 µM) and a reasonable selectivity index (SI = 3-10). Confocal microscopy revealed that the conjugate of propargyl-substituted dispiro-indolinone with the fluorescent dye Sulfo-Cy5-azide was mainly localized in the cytoplasm of HEK293 cells. P388-inoculated mice and HCT116-xenograft BALB/c nude mice were used to evaluate the anticancer activity of compound 29 in vivo. Particularly, the TGRI value for the P388 model was 93% at the final control timepoint. No mortality was registered among the population up to day 31 of the study. In the HCT116 xenograft model, the compound (170 mg/kg, i.p., o.d., 10 days) provided a T/C ratio close to 60% on day 8 after the treatment was completed. The therapeutic index-estimated as LD50/ED50-for compound 29 in mice was ≥2.5. Molecular docking studies were carried out to predict the possible binding modes of the examined molecules towards MDM2 as the feasible biological target. However, such a mechanism was not confirmed by Western blot data and, apparently, the synthesized compounds have a different mechanism of cytotoxic action.
Collapse
Affiliation(s)
- Yan A. Ivanenkov
- Chemistry Department, Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia
- The Federal State Unitary Enterprise Dukhov Automatics Research Institute (VNIIA), 22. ul. Sushchevskaya, 127055 Moscow, Russia
| | - Maxim E. Kukushkin
- Chemistry Department, Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia
| | | | - Radik R. Shafikov
- Chemistry Department, Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, GSP-7, Ulitsa Mklukho-Maklaya 16/10, 17997 Moscow, Russia
- A. N. Belozersky Research Institute of Physico-Chemical Biology MSU, Leninskye Gory, House 1, Building 40, 119992 Moscow, Russia
| | - Alexander A. Barashkin
- Chemistry Department, Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia
| | - Andrey A. Ayginin
- Chemistry Department, Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia
| | - Marina S. Serebryakova
- Chemistry Department, Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia
| | - Alexander G. Majouga
- College of New Materials and Nanotechnologies, National University of Science and Technology MISiS, 119049 Moscow, Russia
| | - Dmitry A. Skvortsov
- Chemistry Department, Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia
| | - Viktor A. Tafeenko
- Chemistry Department, Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia
| | - Elena K. Beloglazkina
- Chemistry Department, Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia
- Correspondence:
| |
Collapse
|
5
|
Methods for substitution of the thioxo group with the oxo group in imidazolidine-2-thione derivatives. Russ Chem Bull 2022. [DOI: 10.1007/s11172-022-3488-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
6
|
Barashkin AA, Polyakov VS, Shikut NL, Putilova AD, Gorovoy AR, Degtiarev AD, Tafeenko VA, Tarasevich BN, Zyk NV, Beloglazkina EK. Diastereoselective cycloaddition of isatin azomethine ylides to 5-arylidene-2-thiohydantoins bearing 3-positioned chiral substituent. MENDELEEV COMMUNICATIONS 2022. [DOI: 10.1016/j.mencom.2022.03.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
7
|
Kukushkin ME, Kondratieva AA, Karpov NA, Shybanov DE, Tafeenko VA, Roznyatovsky VA, Grishin YK, Moiseeva AA, Zyk NV, Beloglazkina EK. [3+2]-Cycloaddition of azomethine ylides to 5-methylidene-3-aryl-2-сhalcogen-imidazolones: access to dispiro indolinone-pyrrolidine-imidazolones. ROYAL SOCIETY OPEN SCIENCE 2022; 9:211967. [PMID: 35291328 PMCID: PMC8905182 DOI: 10.1098/rsos.211967] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Accepted: 02/10/2022] [Indexed: 05/03/2023]
Abstract
A synthesis of dispiro derivatives from 5-methylidene-2-chalcogenimidazolones and azomethine ylides generated from isatins and N-substituted α-amino acids has been developed.
Collapse
Affiliation(s)
- Maxim E. Kukushkin
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russian Federation
| | - Alexandra A. Kondratieva
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russian Federation
| | - Nikita A. Karpov
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russian Federation
| | - Dmitry E. Shybanov
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russian Federation
| | - Viktor A. Tafeenko
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russian Federation
| | - Vitaly A. Roznyatovsky
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russian Federation
| | - Yuri K. Grishin
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russian Federation
| | - Anna A. Moiseeva
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russian Federation
| | - Nikolai V. Zyk
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russian Federation
| | - Elena K. Beloglazkina
- Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1-3, 119991 Moscow, Russian Federation
| |
Collapse
|
8
|
Finko AV, Sokolov AI, Guk DA, Tafeenko VA, Moiseeva AA, Skvortsov DA, Stomakhin AA, Beloglazkin AA, Borisov RS, Pergushov VI, Melnikov MY, Zyk NV, Majouga AG, Beloglazkina EK. Copper coordination compounds with (5 Z,5 Z')-2,2'-(alkane-α,ω-diyldiselenyl)-bis-5-(2-pyridylmethylene)-3,5-dihydro-4 H-imidazol-4-ones. Comparison with sulfur analogue. RSC Adv 2022; 12:7133-7148. [PMID: 35424664 PMCID: PMC8982280 DOI: 10.1039/d1ra08995a] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2021] [Accepted: 02/11/2022] [Indexed: 12/20/2022] Open
Abstract
A series of new organic ligands (5Z,5Z')-2,2'-(alkane-α,ω-diyldiselenyl)-bis-5-(2-pyridylmethylene)-3,5-dihydro-4H-imidazol-4-ones (L) consisting of two 5-(2-pyridylmethylene)-3,5-dihydro-4H-imidazol-4-one units linked with polymethylene chains of various lengths (n = 2-10, where n is the number of CH2 units) have been synthesized. The reactions of these ligands with CuCl2·2H2O and CuClO4·6H2O gave Cu2+ or Cu1+ containing mono- and binuclear complexes with Cu2LCl x (x = 2-4) or CuL(ClO4) y (y = 1, 2) composition. It was shown that the agents reducing Cu2+ to Cu1+ in the course of complex formation can be both a ligand and an organic solvent in which the reaction is carried out. This fundamentally distinguishes the selenium-containing ligands L from their previously described sulfur analogs, which by themselves are not capable of reducing Cu2+ during complexation under the same conditions. A higher cytotoxicity and reasonable selectivity to cancer cell lines for synthesized complexes of selenium-containing ligands was shown; unlike sulfur analogs, ligands L themselves demonstrate a high cytotoxicity, comparable in some cases to the toxicity of copper-containing complexes.
Collapse
Affiliation(s)
- Alexander V Finko
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia .,Topchiev Institute of Petrochemical Synthesis RAS Leninskii pr., 29 Moscow 119991 Russia
| | - Anatolii I Sokolov
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia
| | - Dmitry A Guk
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia
| | - Victor A Tafeenko
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia
| | - Anna A Moiseeva
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia
| | - Dmitry A Skvortsov
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia .,Higher School of Economics Myasnitskaya 13 Moscow 101000 Russia
| | - Andrei A Stomakhin
- Engelhardt Institute of Molecular Biology RAS Vavilova 32 Moscow 119991 Russia
| | - Andrei A Beloglazkin
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia .,Topchiev Institute of Petrochemical Synthesis RAS Leninskii pr., 29 Moscow 119991 Russia
| | - Roman S Borisov
- Topchiev Institute of Petrochemical Synthesis RAS Leninskii pr., 29 Moscow 119991 Russia
| | - Vladimir I Pergushov
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia
| | - Mikhail Ya Melnikov
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia
| | - Nikolay V Zyk
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia
| | - Alexander G Majouga
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia .,National University of Science and Technology Leninskii pr., 4 Moscow 119049 Russia.,Mendeleev University of Chemical Technology Miusskaya pl. 9 Moscow 125047 Russia
| | - Elena K Beloglazkina
- Moscow State University, Department of Chemistry Leninskie Gory, Building 1/3 Moscow 119991 Russia
| |
Collapse
|
9
|
Izmest'ev AN, Streltsov AA, Karnoukhova VA, Kolotyrkina NG, Strelenko YA, Kravchenko AN, Gazieva GA. 5‐Indolylidene‐2‐iminothiazolidin‐4‐ones – Convenient Starting Compounds for Stereoselective Synthesis of Novel Dispirooxindole Derivatives. ChemistrySelect 2022. [DOI: 10.1002/slct.202104128] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Alexei N. Izmest'ev
- N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences 47 Leninsky Prosp. 119991 Moscow Russian Federation
| | - Andrey A. Streltsov
- N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences 47 Leninsky Prosp. 119991 Moscow Russian Federation
- D. I. Mendeleev University of Chemical Technology of Russia 9 Miusskaya Sq. 125047 Moscow Russian Federation
| | - Valentina A. Karnoukhova
- A. N. Nesmeyanov Institute of Organoelement Compounds Russian Academy of Sciences 28 Vavilova Str. 119991 Moscow Russian Federation
| | - Natalya G. Kolotyrkina
- N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences 47 Leninsky Prosp. 119991 Moscow Russian Federation
| | - Yurii A. Strelenko
- N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences 47 Leninsky Prosp. 119991 Moscow Russian Federation
| | - Angelina N. Kravchenko
- N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences 47 Leninsky Prosp. 119991 Moscow Russian Federation
| | - Galina A. Gazieva
- N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences 47 Leninsky Prosp. 119991 Moscow Russian Federation
| |
Collapse
|
10
|
Kukushkin M, Novotortsev V, Filatov V, Ivanenkov Y, Skvortsov D, Veselov M, Shafikov R, Moiseeva A, Zyk N, Majouga A, Beloglazkina E. Synthesis and Biological Evaluation of S-, O- and Se-Containing Dispirooxindoles. Molecules 2021; 26:molecules26247645. [PMID: 34946727 PMCID: PMC8703884 DOI: 10.3390/molecules26247645] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2021] [Revised: 12/06/2021] [Accepted: 12/10/2021] [Indexed: 12/12/2022] Open
Abstract
A series of novel S-, O- and Se-containing dispirooxindole derivatives has been synthesized using 1,3-dipolar cycloaddition reaction of azomethine ylide generated from isatines and sarcosine at the double C=C bond of 5-indolidene-2-chalcogen-imidazolones (chalcogen was oxygen, sulfur or selenium). The cytotoxicity of these dispiro derivatives was evaluated in vitro using different tumor cell lines. Several molecules have demonstrated a considerable cytotoxicity against the panel and showed good selectivity towards colorectal carcinoma HCT116 p53+/+ over HCT116 p53−/− cells. In particular, good results have been obtained for LNCaP prostate cell line. The performed in silico study has revealed MDM2/p53 interaction as one of the possible targets for the synthesized molecules. However, in contrast to selectivity revealed during the cell-based evaluation and the results obtained in computational study, no significant p53 activation using a reporter construction in p53wt A549 cell line was observed in a relevant concentration range.
Collapse
Affiliation(s)
- Maksim Kukushkin
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, GSP-1, 119991 Moscow, Russia; (M.K.); (V.N.); (V.F.); (D.S.); (R.S.); (A.M.); (N.Z.); (A.M.)
- Research Laboratory of Biophysics, National University of Science and Technology MISiS, 119049 Moscow, Russia
| | - Vladimir Novotortsev
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, GSP-1, 119991 Moscow, Russia; (M.K.); (V.N.); (V.F.); (D.S.); (R.S.); (A.M.); (N.Z.); (A.M.)
| | - Vadim Filatov
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, GSP-1, 119991 Moscow, Russia; (M.K.); (V.N.); (V.F.); (D.S.); (R.S.); (A.M.); (N.Z.); (A.M.)
| | - Yan Ivanenkov
- Laboratory of Medicinal Chemistry and Bioinformatic, Moscow Institute of Physics and Technology (MIPT), Institutski Pereulok 9, 141701 Dolgoprudny, Russia; (Y.I.); (M.V.)
| | - Dmitry Skvortsov
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, GSP-1, 119991 Moscow, Russia; (M.K.); (V.N.); (V.F.); (D.S.); (R.S.); (A.M.); (N.Z.); (A.M.)
| | - Mark Veselov
- Laboratory of Medicinal Chemistry and Bioinformatic, Moscow Institute of Physics and Technology (MIPT), Institutski Pereulok 9, 141701 Dolgoprudny, Russia; (Y.I.); (M.V.)
| | - Radik Shafikov
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, GSP-1, 119991 Moscow, Russia; (M.K.); (V.N.); (V.F.); (D.S.); (R.S.); (A.M.); (N.Z.); (A.M.)
| | - Anna Moiseeva
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, GSP-1, 119991 Moscow, Russia; (M.K.); (V.N.); (V.F.); (D.S.); (R.S.); (A.M.); (N.Z.); (A.M.)
| | - Nikolay Zyk
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, GSP-1, 119991 Moscow, Russia; (M.K.); (V.N.); (V.F.); (D.S.); (R.S.); (A.M.); (N.Z.); (A.M.)
| | - Alexander Majouga
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, GSP-1, 119991 Moscow, Russia; (M.K.); (V.N.); (V.F.); (D.S.); (R.S.); (A.M.); (N.Z.); (A.M.)
- Dmitry Mendeleev University of Chemical Technology of Russia, Miusskaya Sq. 9, 125047 Moscow, Russia
| | - Elena Beloglazkina
- Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, GSP-1, 119991 Moscow, Russia; (M.K.); (V.N.); (V.F.); (D.S.); (R.S.); (A.M.); (N.Z.); (A.M.)
- Correspondence:
| |
Collapse
|
11
|
|
12
|
Shybanov DE, Kukushkin ME, Tafeenko VA, Zyk NV, Grishin YK, Roznyatovsky VA, Beloglazkina EK. Different addition modes of cyclopentadiene and furan at methylidene(thio)hydantoins. MENDELEEV COMMUNICATIONS 2021. [DOI: 10.1016/j.mencom.2021.03.034] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|